On the recordSeptember 16, 2015
Has FDA analyzed, No. 1, the extent to which these cost of changing names is passed on to healthcare payers and consumers?
Source
congress.govEditor's note · Context
Senator Hatch questions FDA about cost impacts on healthcare from name changes.
Share
More from Orrin Hatch
Sep 25, 2018
Many of us on the committee have already expressed our concerns about the administration's heavy reliance on tariffs.
Dec 19, 2018
on May 14, 2018, the Supreme Court in Murphy v. NCAA, 138 S. Ct. 1461, 2018, struck down the Federal prohibition of State-authorized sports wagering schemes. I was one of four original authors of that prohibition, the Professional and…
Other voices in this conversation
